Sun Pharma, Cipla recall medicines in US over manufacturing issues

IANS | January 26, 2026 2:12 PM

New Delhi, Jan 26 (IANS) Indian drugmakers Sun Pharmaceutical Industries and Cipla have recalled certain products from the US market due to manufacturing-related issues, according to the latest update from the US Food and Drug Administration (USFDA).

Balochistan perceives CPEC more as a dispossession than development: Report

IANS | January 26, 2026 1:13 PM

New Delhi, Jan 26 (IANS) Balochistan, despite its abundant reserves of natural gas, coal, copper and gold -- remains one of the poorest provinces in Pakistan, a new report has said, adding that for many in Balochistan, “China-Pakistan Strategic Convergence (CPEC) is perceived less as a development opportunity and more as a dispossession”.

MSMEs most powerful platform for job creation: Minister

IANS | January 26, 2026 9:15 AM

New Delhi, Jan 26 (IANS) MSMEs are the most powerful platform for job creation and if India is to become prosperous, there is nothing more effective than MSMEs, according to Minister for MSME, Jitan Ram Manjhi.

PFRDA forms committee to thoroughly review NPS investment guidelines

IANS | January 25, 2026 8:44 PM

New Delhi, Jan 25 (IANS) The Pension Fund Regulatory and Development Authority (PFRDA) has constituted a committee of investment experts for Strategic Asset Allocation and Risk Governance (SAARG) to review, recommend and modernise the investment framework under the National Pension Scheme (NPS), it was announced on Sunday.